28 August 2018 - Late last week, the U.S. Senate passed an amendment to the spending bill that would require pharma companies to disclose the prices of any products they advertise directly to consumers. 

The package devotes $1 million in funding to implement the new requirement, which co-sponsoring Senator Chuck Grassley believes will be vital for bringing “transparency to drug pricing and educating the public about the cost of their prescriptions,” he said in a statement.

This idea has been floating around since early May, when President Donald Trump suggested it as a way to lower prescription drug costs. Shortly after that, FDA Commissioner Scott Gottlieb acknowledged he had put together a working group to examine the intricacies of implementing such a requirement.

Read Forbes magazine article